International Journal of Cardiology
Volume 139, Issue 1 , Pages 80-91 , 18 February 2010

Coronary bifurcation lesions: To stent one branch or both? A meta-analysis of patients treated with drug eluting stents

Received 18 November 2007 ,Revised 2 September 2008 ,Accepted 12 October 2008.

References 

  1. Lefevre T, Louvard Y, Morice MC, et al. Stenting of bifurcation lesions: classification, treatments, and results. Catheter Cardiovasc Interv. 2000;49:274–283
  2. George BS, Myler RK, Stertzer SH, et al. Balloon angioplasty of coronary bifurcation lesions: the kissing balloon technique. Catheter Cardiovasc Diagn. 1986;12:124–138
  3. Aliabadi D, Tilli FV, Bowers TR, et al. Incidence and angiographic predictors of side branch occlusion following high-pressure intracoronary stenting. Am J Cardiol. 1997;80:994–997
  4. Louvard Y, Lefevre T, Morice MC. Percutaneous coronary intervention for bifurcation coronary disease. Heart. 2004;90:713–722
  5. Assali AR, Teplitsky I, Hasdai D, et al. Coronary bifurcation lesions: to stent one branch or both?. J Invasive Cardiol. 2004;16:447–450
  6. Al Suwaidi J, Berger PB, Rihal CS, et al. Immediate and long-term outcome of intracoronary stent implantation for true bifurcation lesions. J Am Coll Cardiol. 2000;35:929–936
  7. Anzuini A, Briguori C, Rosanio S, et al. Immediate and long-term clinical and angiographic results from Wiktor stent treatment for true bifurcation narrowings. Am J Cardiol. 2001;88:1246–1250
  8. Pan M, Suarez de Lezo J, Medina A, et al. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am J Cardiol. 1999;83:1320–1325
  9. Yamashita T, Nishida T, Adamian MG, et al. Bifurcation lesions: two stents versus one stent — immediate and follow-up results. J Am Coll Cardiol. 2000;35:1145–1151
  10. Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology: drug-eluting stents: Part I. Circulation. 2003;107:2274–2279
  11. Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology: drug-eluting stents: Part II. Circulation. 2003;107:2383–2389
  12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  14. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003;326:219
  15. http://www.cochrane.org/resources/handbook.
  16. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  17. Begg CB, Berlin JA. Publication bias: a problem in interpreting medical data. J R Stat Soc. 1988;151:445–463
  18. Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation. 2004;109:1244–1249
  19. Pan M, de Lezo JS, Medina A, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am Heart J. 2004;148:857–864
  20. Ge L, Tsagalou E, Iakovou I, et al. In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent. Am J Cardiol. 2005;95:757–760
  21. Assali AR, Assa HV, Ben-Dor I, et al. Drug-eluting stents in bifurcation lesions: to stent one branch or both?. Catheter Cardiovasc Interv. 2006;68:891–896
  22. Kim YH, Park SW, Hong MK, et al. Comparison of simple and complex stenting techniques in the treatment of unprotected left main coronary artery bifurcation stenosis. Am J Cardiol. 2006;97:1597–1601
  23. Steigen TK, Maeng M, Wiseth R, et al. Nordic PCI Study Group. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation. 2006;114:1955–1961
  24. Valgimigli M, Malagutti P, Rodriguez Granillo GA, et al. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries. Am Heart J. 2006;152:896–902
  25. Di Mario C, Morici N, Godino C, et al. Predictors of restenosis after treatment of bifurcational lesions with paclitaxel eluting stents: a multicenter prospective registry of 150 consecutive patients. Catheter Cardiovasc Interv. 2007;69:416–424
  26. Tsuchida K, Colombo A, Lefevre T, Oldroyd KG, Guetta V, Guagliumi G, et al. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). Eur Heart J. 2007;28:433–442
  27. Lemos PA, Saia F, Ligthart JM, et al. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation. 2003;108:257–260
  28. Sharma SK. Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large-size vessels. Catheter Cardiovasc Interv. 2005;65:10–16
  29. Ge L, Airoldi F, Iakovou I, et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation. J Am Coll Cardiol. 2005;46:613–620
  30. Costa RA, Mintz GS, Carlier SG, et al. Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis. J Am Coll Cardiol. 2005;46:599–605
  31. Jim MH, Ho HH, Chan AO, Chow WH. Stenting of coronary bifurcation lesions by using modified crush technique with double kissing balloon inflation (sleeve technique): immediate procedure result and short-term clinical outcomes. Catheter Cardiovasc Interv. 2007;69:969–975
  32. Galassi AR, Colombo A, Buchbinder M, et al. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the “mini-crush technique”. Catheter Cardiovasc Interv. 2007;69:976–983
  33. Lee MS, Jurewitz D, Aragon J, et al. Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Catheter Cardiovasc Interv. 2006;69:387–394
  34. Aoki J, Nakazawa G, Tanabe K, et al. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. 2006;69:380–386
  35. Dzavik V, Kharbanda R, Ivanov J, et al. Predictors of long-term outcome after crush stenting of coronary bifurcation lesions: importance of the bifurcation angle. Am Heart J. 2006;152:762–769
  36. Boucek RJ, Takeshita R, Brady AH. Microanatomy and intramural physical forces within the coronary arteries (man). Anat Rec. 1965;153:233–241
  37. Brodie BR, Cooper C, Jones M, et al. Is adjunctive balloon postdilatation necessary after coronary stent deployment? Final results from the POSTIT trial. Catheter Cardiovasc Interv. 2003;59:184–192
  38. Porto I, Selvanayagam JB, Van Gaal WJ, et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation. 2006;114:662–669
  39. Chu WW, Kuchulakanti PK, Torguson R, et al. Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006;67:595–599
  40. Kang WC, Oh KJ, Han SH, Ahn TH, Chung WJ, Shin MS, et al. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents. Int J Cardiol. 2007;123:12–17
  41. Burzotta F, Siviglia M, Altamura L, Trani C, Leone AM, Romagnoli E, et al. Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents. Am J Cardiol. 2007;99:364–368
  42. Ong AT, Hoye A, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Sonnenschein K, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol. 2005;45:947–953
  43. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(08)01064-4

doi: 10.1016/j.ijcard.2008.10.016

International Journal of Cardiology
Volume 139, Issue 1 , Pages 80-91 , 18 February 2010

Article Tools

* Image Usage & Resolution